Young-Onset Rectal Cancers on the Rise in US Young-Onset Rectal Cancers on the Rise in US
The incidence of regional and distal rectal cancer among people under 45 is on the rise in the US, a new analysis confirms.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news
Treating Rectal Cancer in the COVID-19 Era: Expert Guidance
An international expert panel has offered new recommendations for treating rectal cancer during the COVID-19 pandemic, which they drew up in 20 days. (Source: WebMD Health)
Source: WebMD Health - April 10, 2020 Category: Consumer Health News Source Type: news
Experts Issue Recommendations for Patients with Rectal Cancer During the COVID-19 Pandemic
Leading cancer experts from across Europe issued an international expert consensus statement regarding radiotherapy treatment options for patients with rectal cancer during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 10, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Treating Rectal Cancer in the COVID-19 Era: Expert Guidance Treating Rectal Cancer in the COVID-19 Era: Expert Guidance
An international expert panel has offered new recommendations for treating rectal cancer during the COVID-19 pandemic, which they drew up in 20 days.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 9, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
New drug combination passes safety test in pancreatic cancer
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study has shown a novel peptide antagonist, given in combination with a PD-1 inhibitor, to be safe and well-tolerated in patients with advanced, refractory pancreatic and rectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2020 Category: Cancer & Oncology Source Type: news
Half of new colorectal cancer diagnoses are now in people 66 and younger, report finds
The median age at which people are diagnosed with colon and rectal cancer has dropped to 66, according to a new report from the American Cancer Society. Colorectal cancer incidence among adults younger than 50 has been increasing since the mid-1990s. (Source: CNN.com - Health)
Source: CNN.com - Health - March 5, 2020 Category: Consumer Health News Source Type: news
Half of new colon and rectal cancer diagnoses are now in people age 66 and younger, report finds
Colon and rectal cancer cases are on the rise in young adults, according to a new report from the American Cancer Society. (Source: CNN.com - Health)
Source: CNN.com - Health - March 5, 2020 Category: Consumer Health News Source Type: news
Organ-Preserving Local Excision Feasible for Certain Small Rectal Cancers Organ-Preserving Local Excision Feasible for Certain Small Rectal Cancers
Organ-preserving local excision is feasible for selected patients with small rectal cancers that show a good clinical response after chemotherapy, according to five-year results from a clinical trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 27, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news
' Watch & Wait' in Rectal Cancer Doesn't Compromise Outcomes'Watch & Wait' in Rectal Cancer Doesn't Compromise Outcomes
Another study adds support for taking a watch-and-wait (W&W) approach for patients with low rectal tumors instead of recommending immediate surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Do Your Devices Meet Physicians ’ Needs?
You’ve invested a lot of time ensuring your medical device meets user needs, but could those needs have changed? As healthcare evolves thanks to robotics, value-based care, the rise of ambulatory surgery centers, remote procedures, and more, the needs of surgeons and other physicians and healthcare practitioners are evolving, too.
Physicians will come together at the upcoming MD&M West 2020 conference to discuss what is missing in the world of medtech in the panel discussion, Tech Talk Panel: Physician's Perspectives: Unmet Needs, Design, & New Technologies in Medtech.
Participating on the panel w...
Source: MDDI - February 7, 2020 Category: Medical Devices Authors: Daphne Allen Tags: Design Source Type: news
'Watch-and-Wait' strategy could safely replace surgery in more than 20% of rectal cancers
(Champalimaud Centre for the Unknown) This therapeutic approach is still far from being mainstream practice. But according to the latest research, it could actually prevent hundreds of thousands of invasive surgeries worldwide every year. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2020 Category: International Medicine & Public Health Source Type: news
Studies Support Use of the Accuray TomoTherapy(R) System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
SUNNYVALE, Calif., Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy® System in the treatment of advanced rectal cancer. Radio... Devices, Oncology Accuray, radiotherapy, TomoTherapy, Radixact, rectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2020 Category: Pharmaceuticals Source Type: news
Steep Increase Seen in Incidence of CRC From Age 49 to 50 Years
Increases seen across the U.S., in men and women, in whites and blacks, for colon and rectal cancers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pathology, Journal, Source Type: news
Strong Support Network Is Key to Women's Cancer Recovery: Study
MONDAY, Feb. 3, 2020 -- Older women with colon or rectal cancer are more likely to die early if they lack support from family, friends or others, a new study finds.
For the study, researchers looked at more than 1,400 postmenopausal women with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news
